Vyne Therapeutics Inc.
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 45 institutions reported holding Vyne Therapeutics Inc. in their 13F filings, unchanged from Q1 2026. 6 opened new positions and 4 sold out. The largest holders were ADAR1 Capital Management, LLC ($1.9M), Nantahala Capital Management, LLC ($1.3M) and Lynx1 Capital Management LP ($1.1M). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Vyne Therapeutics Inc.
- CUSIP
- 92941V308
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $113K |
| Exits | 4 | $66K |
All 13F filers, Q1 2026 → Q2 2026: 2,169,356 shares bought and 1,864,151 shares sold, net +305,205 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 45 holders
| ADAR1 Capital Management, LLC | 0.09% | Add +177.3% | 2,950,000 | $1.9M |
| Nantahala Capital Management, LLC | 0.08% | No change | 2,000,000 | $1.3M |
| Lynx1 Capital Management LP | 0.12% | No change | 1,628,700 | $1.1M |
| Shay Capital LLC | 0.10% | Reduce -9.5% | 1,456,651 | $948K |
| T3 Companies, LLC | 0.72% | No change | 945,000 | $615K |
| Braidwell LP | 0.02% | No change | 916,077 | $596K |
| KVP Capital Advisors, LP | 0.24% | No change | 500,551 | $326K |
| Citadel Advisors | 0.00% | Reduce -8.9% | 468,457 | $305K |
| Two Sigma Investments, LP | 0.00% | Add +2.9% | 438,818 | $286K |
| Acadian Asset Management LLC | 0.00% | No change | 381,797 | $248K |
| Ikarian Capital, LLC | 0.03% | No change | 264,912 | $172K |
| Vanguard Capital Management LLC | 0.00% | No change | 264,557 | $172K |
| Geode Capital Management, LLC | 0.00% | Reduce -20.0% | 258,203 | $168K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 183,443 | $119K |
| Susquehanna International Group, LLP | 0.00% | Add +105.9% | 118,957 | $77K |
| Rangeley Capital, LLC | 0.07% | Reduce -4.2% | 113,064 | $74K |
| XTX Topco Ltd | 0.00% | Reduce -50.3% | 78,721 | $51K |
| Gsa Capital Partners LLP | 0.00% | New | 71,533 | $47K |
| Superstring Capital Management LP | 0.03% | New | 61,269 | $40K |
| UBS Group AG | 0.00% | Reduce -67.4% | 58,597 | $38K |
| BlackRock, Inc. | 0.00% | No change | 44,405 | $29K |
| Northern Trust Corp. | 0.00% | Add +89.0% | 43,677 | $28K |
| Jane Street Group, LLC | 0.00% | Reduce -57.2% | 40,974 | $27K |
| Two Sigma Securities, LLC | 0.00% | New | 40,697 | $26K |
| FNY Investment Advisers, LLC | 0.01% | No change | 35,000 | $22K |
| Renaissance Technologies | 0.00% | Add +34.7% | 23,300 | $15K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 18,298 | $12K |
| State Street Corp. | 0.00% | No change | 15,765 | $10K |
| Anson Funds Management LP | 0.00% | Reduce -98.8% | 14,455 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +268.4% | 12,994 | $8K |
| Harvest Investment Services, LLC | 0.00% | No change | 11,059 | $7K |
| Acorn Capital Advisors, LLC | 0.00% | No change | 1,425 | $926 |
| Mb, Levis & Associates, LLC | 0.00% | No change | 1,041 | $677 |
| Hurley Capital, LLC | 0.00% | No change | 561 | $365 |
| Barclays PLC | 0.00% | New | 141 | $92 |
| Wells Fargo & Company | 0.00% | No change | 65 | $42 |
| Morgan Stanley | 0.00% | No change | 43 | $28 |
| Truvestments Capital LLC | 0.00% | No change | 25 | $16 |
| NFSG Corp | 0.00% | No change | 10 | $7 |
| JPMorgan Chase & Co. | 0.00% | Reduce -94.5% | 8 | $5 |
| Steward Partners Investment Advisory, LLC | 0.00% | New | 1 | $1 |
| Larson Financial Group LLC | 0.00% | No change | 2 | $1 |
| Flagship Wealth Advisors, LLC | 0.00% | New | 1 | $1 |
| Royal Bank of Canada | 0.00% | No change | 15 | $0 |
| Centerpoint Advisors, LLC | 0.00% | No change | 350 | $0 |
"% of holder's portfolio" is VYNE THERAPEUTICS INC's weight in each manager's 13F, not the share of Vyne Therapeutics Inc. the manager owns.